Cargando…

Membranous nephropathy following anti–COVID-19 mRNA vaccination

Detalles Bibliográficos
Autores principales:	Gueguen, Lorraine, Loheac, Charlotte, Saidani, Nadia, Khatchatourian, Lydie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376522/ https://www.ncbi.nlm.nih.gov/pubmed/34419553 http://dx.doi.org/10.1016/j.kint.2021.08.006

Ejemplares similares

The humoral response of mRNA COVID-19 vaccine in hematological diseases: The HEMVACO study
por: Gueguen, M., et al.
Publicado: (2022)

A case of membranous nephropathy following Pfizer–BioNTech mRNA vaccination against COVID-19
por: Da, Yi, et al.
Publicado: (2021)

Painless thyroiditis following mRNA vaccination for COVID-19
por: Nakaizumi, Nobuhiko, et al.
Publicado: (2022)

Panuveitis following mRNA-based COVID-19 vaccine
por: Bouayad, A., et al.
Publicado: (2023)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

COVID-19 Vaccination in Patients With Membranous Nephropathy
por: Visch, Ruben, et al.
Publicado: (2022)

Ramsay Hunt syndrome following mRNA SARS-COV-2 vaccine()
por: Rodríguez-Martín, Minerva, et al.
Publicado: (2022)

Adult-onset Still's disease following mRNA COVID-19 vaccination
por: Sharabi, Amir, et al.
Publicado: (2021)

Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2022)

Thromboembolic events following mRNA vaccines for COVID 19: a case series
por: Serrao, Alessandra, et al.
Publicado: (2022)

No evidence of an increased risk for cardiac complications following mRNA COVID-19 vaccines
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2023)

No evidence of an increased risk for cardiac complications following mRNA COVID-19 vaccines
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2023)

Myocarditis and COVID-19 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2021)

Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Acute gastric and non-mesenteric colonic infarction following mRNA COVID-19 vaccination
por: Lee, Taek-Gu, et al.
Publicado: (2022)

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
por: Kervella, Delphine, et al.
Publicado: (2021)

Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Corticosteroids and mRNA Vaccines: A Word of Caution
por: Zhong, Zifu, et al.
Publicado: (2021)

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

In reply to “Anti-alpha-enolase antibodies in membranous nephropathy: isotype matters”
por: Imai, Hirokazu, et al.
Publicado: (2016)

First Diagnosis of Immunoglobulin A Nephropathy Following SARS-CoV-2 mRNA Vaccination in Japan
por: Yokote, Shinya, et al.
Publicado: (2022)

Membranous nephropathy and carbamazepine
por: Sangeetha, B., et al.
Publicado: (2014)

Vasculitic flare in a patient with anti-myelin-associated glycoprotein (MAG) antibody following mRNA-1273 SARS-CoV-2 vaccine
por: Briani, Chiara, et al.
Publicado: (2022)

Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report
por: Masuccio, Fabio Giuseppe, et al.
Publicado: (2021)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response
por: Masset, Christophe, et al.
Publicado: (2021)

Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality?
por: Pasin, Federico, et al.
Publicado: (2021)

« Et si nous vaccinions directement dans les services? » Évaluation de la tolérance du vaccin AztraZeneca chez les soignants sur la première semaine de campagne vaccinale
por: Cloarec, E., et al.
Publicado: (2021)

Passive inhaled mRNA vaccination for SARS-Cov-2
por: Yeo, Wee Song, et al.
Publicado: (2021)

Temporal metabolic response and mRNA COVID-19 vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis
por: Faissner, Simon, et al.
Publicado: (2021)

Effectiveness of mRNA Covid-19 vaccine in healthcare workers
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Effectiveness of mRNA Covid-19 vaccine in healthcare workers
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

COVID-19 mRNA vaccination in patients with previous myocarditis
por: Pieroni, Maurizio, et al.
Publicado: (2022)

mRNA vaccination in children and youth: a cautionary note
por: Sergi, Consolato M.
Publicado: (2022)

Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine”
por: Schwotzer, Nora, et al.
Publicado: (2021)

Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV-2 mRNA vaccination
por: Sacker, Allan, et al.
Publicado: (2021)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines
por: Teo, Shyh Poh
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vo1pqvh1vl19d75cs8i5vhst03